rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1994-1-25
|
pubmed:abstractText |
We and others have demonstrated that administration of thrombolytic agents causes the generation of thrombosis-promoting agents. At present, we have studied whether formation in vivo of excessive amounts of plasmin is responsible for the activation of coagulation in patients treated with recombinant tissue-type plasminogen activator.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0954-6928
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
371-7
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:8261210-Aged,
pubmed-meshheading:8261210-Antithrombin III,
pubmed-meshheading:8261210-Blood Coagulation,
pubmed-meshheading:8261210-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:8261210-Female,
pubmed-meshheading:8261210-Fibrin Fibrinogen Degradation Products,
pubmed-meshheading:8261210-Fibrinolysin,
pubmed-meshheading:8261210-Humans,
pubmed-meshheading:8261210-Immunoelectrophoresis, Two-Dimensional,
pubmed-meshheading:8261210-Male,
pubmed-meshheading:8261210-Middle Aged,
pubmed-meshheading:8261210-Myocardial Infarction,
pubmed-meshheading:8261210-Peptide Hydrolases,
pubmed-meshheading:8261210-Plasminogen,
pubmed-meshheading:8261210-Prothrombin,
pubmed-meshheading:8261210-Recombinant Proteins,
pubmed-meshheading:8261210-Thrombolytic Therapy,
pubmed-meshheading:8261210-Tissue Plasminogen Activator,
pubmed-meshheading:8261210-alpha-2-Antiplasmin
|
pubmed:year |
1993
|
pubmed:articleTitle |
Reactive coagulation induced by plasmin in patients treated with recombinant tissue-type plasminogen activator.
|
pubmed:affiliation |
Department of Clinical Chemistry, Ribe County Hospital, Esbjerg, Denmark.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|